Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?

Recent news of an impending clinical cell transplantation trial in Parkinson’s disease using parthenogenetic stem cells as a source of donor tissue have raised hopes in the patient community and sparked discussion in the research community. Based on discussions held by a global collaborative initiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Barker, Roger A., Parmar, Malin, Kirkeby, Agnete, Björklund, Anders, Thompson, Lachlan, Brundin, Patrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927930/
https://www.ncbi.nlm.nih.gov/pubmed/27003785
http://dx.doi.org/10.3233/JPD-160798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927930/
https://www.ncbi.nlm.nih.gov/pubmed/27003785
http://dx.doi.org/10.3233/JPD-160798

Ejemplares similares